Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12625520rdf:typepubmed:Citationlld:pubmed
pubmed-article:12625520lifeskim:mentionsumls-concept:C0034380lld:lifeskim
pubmed-article:12625520lifeskim:mentionsumls-concept:C1556085lld:lifeskim
pubmed-article:12625520lifeskim:mentionsumls-concept:C0010674lld:lifeskim
pubmed-article:12625520lifeskim:mentionsumls-concept:C0034394lld:lifeskim
pubmed-article:12625520lifeskim:mentionsumls-concept:C0348000lld:lifeskim
pubmed-article:12625520lifeskim:mentionsumls-concept:C1527075lld:lifeskim
pubmed-article:12625520lifeskim:mentionsumls-concept:C1519941lld:lifeskim
pubmed-article:12625520pubmed:issue1lld:pubmed
pubmed-article:12625520pubmed:dateCreated2003-3-10lld:pubmed
pubmed-article:12625520pubmed:abstractTextThe assessment of health related quality of life (HRQOL) has increasingly been recognized as an important adjunct to medical outcome parameters in the monitoring of cystic fibrosis (CF) patients and in clinical studies. The Cystic Fibrosis Questionnaire (CFQ) is a disease-specific HRQOL instrument for CF patients developed in France. Translations are currently being validated in four different countries. The aim of the present study was to validate the German adaptation of the CFQ-14+.lld:pubmed
pubmed-article:12625520pubmed:languageenglld:pubmed
pubmed-article:12625520pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12625520pubmed:citationSubsetIMlld:pubmed
pubmed-article:12625520pubmed:statusMEDLINElld:pubmed
pubmed-article:12625520pubmed:monthFeblld:pubmed
pubmed-article:12625520pubmed:issn0962-9343lld:pubmed
pubmed-article:12625520pubmed:authorpubmed-author:WahnUlrichUlld:pubmed
pubmed-article:12625520pubmed:authorpubmed-author:StaabDorisDlld:pubmed
pubmed-article:12625520pubmed:authorpubmed-author:WenningerKers...lld:pubmed
pubmed-article:12625520pubmed:authorpubmed-author:AussagePierre...lld:pubmed
pubmed-article:12625520pubmed:authorpubmed-author:German...lld:pubmed
pubmed-article:12625520pubmed:issnTypePrintlld:pubmed
pubmed-article:12625520pubmed:volume12lld:pubmed
pubmed-article:12625520pubmed:ownerNLMlld:pubmed
pubmed-article:12625520pubmed:authorsCompleteYlld:pubmed
pubmed-article:12625520pubmed:pagination77-85lld:pubmed
pubmed-article:12625520pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:12625520pubmed:meshHeadingpubmed-meshheading:12625520...lld:pubmed
pubmed-article:12625520pubmed:meshHeadingpubmed-meshheading:12625520...lld:pubmed
pubmed-article:12625520pubmed:meshHeadingpubmed-meshheading:12625520...lld:pubmed
pubmed-article:12625520pubmed:meshHeadingpubmed-meshheading:12625520...lld:pubmed
pubmed-article:12625520pubmed:meshHeadingpubmed-meshheading:12625520...lld:pubmed
pubmed-article:12625520pubmed:meshHeadingpubmed-meshheading:12625520...lld:pubmed
pubmed-article:12625520pubmed:meshHeadingpubmed-meshheading:12625520...lld:pubmed
pubmed-article:12625520pubmed:meshHeadingpubmed-meshheading:12625520...lld:pubmed
pubmed-article:12625520pubmed:meshHeadingpubmed-meshheading:12625520...lld:pubmed
pubmed-article:12625520pubmed:meshHeadingpubmed-meshheading:12625520...lld:pubmed
pubmed-article:12625520pubmed:meshHeadingpubmed-meshheading:12625520...lld:pubmed
pubmed-article:12625520pubmed:year2003lld:pubmed
pubmed-article:12625520pubmed:articleTitleThe revised German Cystic Fibrosis Questionnaire: validation of a disease-specific health-related quality of life instrument.lld:pubmed
pubmed-article:12625520pubmed:affiliationDepartment for Paediatric Pneumology and Immunology, Charité-Humboldt University, Berlin, Germany.lld:pubmed
pubmed-article:12625520pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12625520pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:12625520pubmed:publicationTypeValidation Studieslld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12625520lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12625520lld:pubmed